Observational Study
Copyright ©The Author(s) 2017.
World J Stem Cells. Dec 26, 2017; 9(12): 227-234
Published online Dec 26, 2017. doi: 10.4252/wjsc.v9.i12.227
Figure 1
Figure 1 Survival of acute myeloid leukemia patients (without palliative) according to 1% CD34+CD38- cut-off. A: Disease free survival; B: Overall survival.

  • Citation: Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X. High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia. World J Stem Cells 2017; 9(12): 227-234
  • URL: https://www.wjgnet.com/1948-0210/full/v9/i12/227.htm
  • DOI: https://dx.doi.org/10.4252/wjsc.v9.i12.227